drugset / Trial / NCT01634347

Memory Reconsolidation Blockade for Treating Drug Addiction

NCT01634347

Phase 2 Completed 17 enrolled Douglas Mental Health University Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The treatment involves administering propranolol, a medication indicated for treating high blood pressure. Propranolol is hypothesized to reduce the strength of drug or alcohol cravings (an integral factor involved in relapse), specifically when memories of substance use are recalled. In this study, propranolol or a placebo will be administered to patients participating in a drug or alcohol rehabilitation facility once a week over three or six weeks. After receiving propranolol or placebo, strong memories associated with substance craving are recalled by asking participants to read aloud a summary of a substance use experience. The investigators hypothesize that participants who receive propranolol will report fewer and less intense drug or alcohol cravings than participants who receive the placebo or treatment-as-usual.

Timeline

Start
2012-01
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 1 mg/kg

Indications